RP-HPLC Method for Determination of Several NSAIDs and Their Combination Drugs

Table 9

Quantitative determination in pharmaceutical formulations.

Formulation examined	API	Label claim (mg)	Amount found (Mean ± SD) (mg)	Recovery (%)	RSD (%) (𝑛=6)
CLAVIX-AS tab	CLP	75	75.15±0.1	100.17	0.14
	ASP	150	150.04±0.5	100.03	0.32
DEXA-P tab	PCM	125	124.90±0.3	99.92	0.21
	CPM	1	0.99±0.02	98.97	1.7
	DXM	5	5.07±0.1	101.48	1.81
THIOCECLO tab	ACF	100	99.92±0.3	99.92	0.32
	THC	4	4.01±0.1	100.33	1.37
CETADOM tab	PCM	500	499.61±0.8	99.92	0.16
	DOM	10	10.03±0.1	100.33	0.9
MILFLOX PLUS eye drops	MCX	5	4.92±0.1	98.4	1.74
	KTL	5	5.05±0.1	101	1.62
SUPAMOVE-4 cap	THC	4	4.02±0.1	100.4	1.76
	DCF	50	49.70±0.3	99.39	0.58
ARTIGESIC tab	IBU	400	399.35±1.2	99.84	0.31
	PCM	325	325.30±0.9	100.06	0.27
NUCOXIA-P tab	ETC	60	59.90±0.3	99.84	0.53
	PCM	500	500.21±0.6	100.04	0.12
NAPRA-D tab	NPX	250	249.72±0.4	99.89	0.16
	DOM	10	9.98±0.2	99.76	1.73